Chrono Therapeutics
The report suggests technology could help address variability in care and boost addiction treatment enrollment.
The National Cancer Institute (NCI) has awarded Chrono Therapeutics a Small Business Innovation Research (SBIR) grant of up to $2.
Chrono Therapeutics, a Hayward, California-based company working on a new wearable for smoking cessation and drug delivery, has raised $32 million in its first round of funding.